These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival. Hammond PJ; Murphy D; Carachi R; Davidson DF; McIntosh D J Pediatr Surg; 2010 Feb; 45(2):383-6. PubMed ID: 20152357 [TBL] [Abstract][Full Text] [Related]
7. Paediatric bilateral adrenal phaeochromocytomas in association with a novel mutation in the von Hippel Lindau gene. Kim L; Holland AJ; Srinivasan S; Cowell CT; Benn DE; Robinson BG J Paediatr Child Health; 2008 Sep; 44(9):514-6. PubMed ID: 18928468 [TBL] [Abstract][Full Text] [Related]
8. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations. Mora J; Cascón A; Robledo M; Catala A Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664 [TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma: an update on genetics and management. Karagiannis A; Mikhailidis DP; Athyros VG; Harsoulis F Endocr Relat Cancer; 2007 Dec; 14(4):935-56. PubMed ID: 18045948 [TBL] [Abstract][Full Text] [Related]
10. Germline SDHD mutation in familial phaeochromocytoma. Astuti D; Douglas F; Lennard TW; Aligianis IA; Woodward ER; Evans DG; Eng C; Latif F; Maher ER Lancet; 2001 Apr; 357(9263):1181-2. PubMed ID: 11323050 [TBL] [Abstract][Full Text] [Related]
11. When should genetic testing be obtained in a patient with phaeochromocytoma or paraganglioma? Erlic Z; Neumann HP Clin Endocrinol (Oxf); 2009 Mar; 70(3):354-7. PubMed ID: 19067729 [TBL] [Abstract][Full Text] [Related]
12. Duodenal carcinoid tumours, phaeochromocytoma and neurofibromatosis: islet cell tumour, phaeochromocytoma and the von Hippel-Lindau complex: two distinctive neuroendocrine syndromes. Griffiths DF; Williams GT; Williams ED Q J Med; 1987 Sep; 64(245):769-82. PubMed ID: 2897130 [TBL] [Abstract][Full Text] [Related]
13. Novel SDHD germ-line mutations in pheochromocytoma patients. Neumayer C; Moritz A; Asari R; Weinhäusel A; Hölzenbein T; Kretschmer G; Niederle B; Haas OA Eur J Clin Invest; 2007 Jul; 37(7):544-51. PubMed ID: 17576205 [TBL] [Abstract][Full Text] [Related]
14. Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Benn DE; Richardson AL; Marsh DJ; Robinson BG Ann N Y Acad Sci; 2006 Aug; 1073():104-11. PubMed ID: 17102077 [TBL] [Abstract][Full Text] [Related]
15. Novel mutation in the TMEM127 gene associated with phaeochromocytoma. Elston MS; Meyer-Rochow GY; Prosser D; Love DR; Conaglen JV Intern Med J; 2013 Apr; 43(4):449-51. PubMed ID: 23551308 [TBL] [Abstract][Full Text] [Related]
16. Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations. Ercolino T; Becherini L; Valeri A; Maiello M; Gaglianò MS; Parenti G; Ramazzotti M; Piscitelli E; Simi L; Pinzani P; Nesi G; Degl'Innocenti D; Console N; Bergamini C; Mannelli M Clin Endocrinol (Oxf); 2008 May; 68(5):762-8. PubMed ID: 18031321 [TBL] [Abstract][Full Text] [Related]
19. Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Bornstein SR; Gimenez-Roqueplo AP Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076 [TBL] [Abstract][Full Text] [Related]